IMMUCELL CORP /DE/ — Director's Dealing 2024

Aug 30, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2024-08-28

Reporting Person: Tomsche David Scott (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-28	Common stock $0.10 per value per share	D	2186	$3.55	Acquired	131797	Direct

Footnotes

F1: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.